who invented glp 1 drugs How Lotte Bjerre Knudsen helped kick off the Age of Wegovy Richard DiMarchi, pioneering IU peptide

Sirohi et al

Local pharma giants arent standing still

Anyone with a BMI of 30 or above, or 27 with at least one weight-related comorbidity, meets the standard prescribing criteria for GLP-1 therapy

Professional medical societies actively engage in developing clinical practice guidelines and treatment quality standards

Next generation of obesity drugs - combination By the time Novo Nordisk's scientists had unlocked the potential of GLP-1 for obesity, a number of other researchers elsewhere were beginning to also explore its potential

The elimination of cold chain constraints alone has major implications for emerging markets, where infrastructure has traditionally limited GLP-1 adoption despite high disease burden